Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$KNDI Q2 revenue growth of 54.1%, beating the analyst consensus of $20.80 million.
$IDEX Ideanomics is shaping the future of commercial fleet operations by assembling a synergistic ecosystem of subsidiaries and investments across the three key pillars of EV: Vehicles, Charging, and Energy. With cutting-edge proven solutions, we are reducing the total cost of ownership for fleet operators, together with harmful greenhouse gas emissions.
https://ideanomics.com/
$KITL you beat me to it. This has a shot
$NAK Northern Dynasty Minerals The Pebble Mine contains billions of pounds of rare earth elements. https://instituteforenergyresearch.org/renewable/pebble-mine-could-reduce-dependence-on-china-for-critical-metals/
$NIHK gives me those P2DI vibes. Much great news pending including a JV with Chinese EV Manu.
$AMMX is a mom and pop excavation business...May actually hit a buck. Had a r/s so the o/s is very small relatively speaking.
Identifying Criteria for P2DI Opportunities
1. The Stock has to trade reasonable volume daily - relative to its average
2. Increasing revenue stream or better yet profitability. - IOW Reporting
3. A strong product base with expansion potential - consumables a big plus
4. 200M - 400M O/S - However it could be higher depending on the Revenues/Earnings generated should be taken into account.
5. Insiders should own shares
6. No dilution to line pockets - must be accretive
7. Management previous history of success is important
8. A Prime mover behind it or strong potential for buyout
9. Any Bloated float Stocks (In General) and those with share structures in the Billions are immediately disqualified.
$INTV is a recent candidate for penny to dollar land.
$FTRS - Has now joined the ranks of an official penny to dollar company. Let the success flow because this is just the tip of the iceberg
Three Potentials MITI, ENZC and ENZN...
Don't know how but TSNP has cracked a buck...From trip zero to $1.23 is simply amazing...so many millionaires made. (Not me on that ride) damit. Sold way to early...
MITI - Is a candidate to break a buck one day...
PNNX has penny to dollar potential...small float and o/s excitement building
RVVTF and approval away from a Buck break....
TSNP - Hard to believe but this one may actually run to a buck. I am wary of what will happen if they don't PR something big before the CC at 5PM on the 9th... www.HUMBLpay.com
EXROF - continues to climb. Solidifying its position as one of the most penny to dollar stocks out there. So much more upside to come.
FTRS - A reverse merger play that is acquiring companies. Great Penny to dollar potential
See link on acquisitions
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159054268
8K here:
https://www.otcmarkets.com/filing/conv_pdf?id=14442946&guid=p7PeUnwhj2Skith
EXROF is now $1.39. A true P2D Success story
RVVTF should trade over a buck even before Phase 3 human trials are done. Still under 3 cents. and a bargain...
Cgld https://www.buscarcompany.com/milestones
CGLD 76.00% % of Shares Held by All Insider https://finance.yahoo.com/quote/CGLD/ CGLD=$$$$
https://a4270d14-14b9-4db5-b44e-ca57d78cafd8.filesusr.com/ugd/b0eadd_909642b968ef40c79d01824b081a5714.pdf So $4.298bn / 18,683m Outstanding shares gives a current net asset value of $230/share. the value of the reserves above is based on $1200 per ounce. Gold is at $1700 per ounce today! I’ll let everyone ponder what the increase in net asset value per share is for themselves! Share Structure https://www.otcmarkets.com/stock/CGLD/security
EXROF got an early $1 on the bid...
EXROF @ 92 cents....a real challenger to break a buck. Fingers crossed.
Same with this one
OS - 46,957,322 https://t.co/J5Jc9ZenjShttps://t.co/XE72KDzSt2$goog $fb $msft $socl $renn $sina $twtr $angi $yelp $momo $ipdn $meet $yy $cyou $ntes $znga
— PENNIES to STACKS (@PENNIEStoSTACKS) February 23, 2020
@ClayTrader25 @i_like_bb_stock @READY_2_PROFIT @rigatoni33 @shakerzstocks @RULiquid @HDOGTX https://t.co/pLj7FZ75YR
$KDNG could go from pennies 2 dollars. Nice merger consummated today.
P2DI Update - RELI should crack a buck mid to late Feb or when they actually release new news with accretive content. EXROF took a major technical downturn when it got ahead of itself. I expect it to churn until new news of partnership/collaboration hits. Got to think long term with tech stocks. Finally new comer EMPM has extreme hype behind its possibilities with Korean back investors is electronic cars wanting to go public American style...The market technical are on a downward trend but if 1.5 of the shit being spewed comes true this should move up for a nice pay day. RCO - Risk Capital Only...
Progress report EXROF sold off and is churning in the low 30s. Fully expect next cycle up soon. RELI continues its run towards a buck. No support is being established so a huge sell off is coming but from what price point is the question. . However it should be short lived because lots of good news in the pipeline...finally EMPM may be a new sleeper to see a buck. Hype is massive on this one
Progress report reli is now 62 cent. Exrof is at 46 cents...charts look fabulous
RELI and EXROF running hot toward a buck....
2020 candidates are RELI, EXROF and RLBY
RLBY may see a buck or 2 before the year is out.
Two prospects I currently hold. One tech EXROF and RELI a reverse merger which is now in its defining qtr. Both in the low 20 cent range.
SHMP had crossed. 84 cents.... I think it kisses a buck tomorrow
SHMP - rallying hard to reach that dollar mark...Closed at 50 cents..
Potential P2DIs to watch RELI & SHMP
.
.
.
WDBG,,,RM into a fully reporting shell. Nasdaq listing is the ultimate goal this year. Lots of moving parts with this one and quite a cast of posters.
$RELI is the new ticker a rare find in OTC.
EOMN now RELI - Definite P2DI reverse merger - still need to get info on how the share restructuring will play out. Last R/M I was in is now up 6500% - and a 25-1 r/s did not hinder progress...
$EOMN Debt Free New CEO has billions in assets:
https://www.relianceglobalholdings.com/properties http://ezrabeyman.org
Property Name Address City State Zip (Units)
Amberidge 32864 AMBRIDGE DR. ROSEVILLE MI 48066 (45)
Ashgrove 7701 HOGANS RUN LOUISVILLE KY 40228 (60)
Beckford Place 36 POSTON ROAD #20 THE PLAINS OH 45780 (60)
Camellia Court 3835 BETH ANNE DRIVE COLUMBUS OH 43207 (104)
Carleton Court 2976 CASCADE DR. ANN ARBOR MI 48104 (104)
Cedarwood 1306-C CEDARBROOK DRIVE GOSHEN IN 46526 (90)
Dover Place 34850-M LAKE SHORE BLVD EASTLAKE OH 44095 (229)
Elmwood 1705 ROSWELL RD. NE #1 MARIETTA GA 30062 (48)
Forsythia Court 1481 BUNCH LINE DR. WESTERVILLE OH 43081 (60)
Foxhaven 4171 FOXHAVEN AVE. NW CANTON OH 44718 (107)
Hayfield Park 5519-C LIMABURG RD. BURLINGTON KY 41005 (86)
Laurel Bay 1632 W. LAUREL BAY DR. YPSILANTI MI 48198 (68)
Meadowood 8611 MEADOWOOD DR. NEWBURGH IN 47630 (65)
Ridgewood 3326 MICHAEL AVENUE #110 BEDFORD IN 47421 (98)
River Glen 1184 FOXCREEK LANE REYNOLDSBURG OH 43068 (113)
Slate Run 450 TURNEY ROAD BEDFORD OH 44146 (62)
Tabor Ridge 80 EMERSON AVENUE #10000 BEREA OH 44017 (97)
Willowood 220 TUPELO TRAIL #10 FRANKFORT KY 40601 (110)
Wood Trail 247 JACKSON STREET NEWNAN GA 30263 (61)
Garden Terrace 8725 Del Rey Court 10B Tampa FL 33617 (212)
Riverwood 4803 St. Johns Ave Office Palatka FL 32177 (68)
Hickory Place 2323 SW 35Th Place - Office Gainesville FL 32608 (70)
Holly Sands 5 Sandalwood Dr. NW - Office Ft. Walton Bch FL 32548 (124)
Willow Run 4941 Central Drive #1205 Stone Mountain GA 30083 (72)
Forest Village 1481 Forest Hill Road #102 Macon GA 31210 (83)
Ridgewood 3863 Memorial Dr. #101 Decatur GA 30032 (114)
Meadowland 200 Crane Drive Apt. #61 Athens GA 30606 (60)
Oakley Woods 6300 Oakley Road Union City GA 30291 (60)
Barrington 750 Northern Avenue Clarkston GA 30021 (47)
Ramblewood 2549 Center West Pkwy Augusta GA 30909 (186)
Countryside Manor 8800 Countryside Way Douglasville GA 30134 (82)
Willow Creek 101 Rhodes Lane Griffin GA 30224 (53)
Timberwood 710 Mason Terrace Road #11 Perry GA 31069 (60)
Carriage Hill 604 Hillcrest Pkwy. #1 Dublin GA 31021 (60)
Whisperwood 1506 East 16Th Ave. Apt.# 1E Cordele GA 31015 (50)
Harbinwood 1295 Harbins Road Norcross GA 30093 (72)
Northridge 400 Northside Dr. Apt A Carrollton GA 30117 (77)
Laurel Glen 4191 Lake Acworth Dr Acworth GA 30101 (81)
Morgan Trace 4065 Jonesboro Road Union City GA 30291 (80)
Valleybrook 169 Roscoe Road Newnan GA 30263 (71)
Glenwood Village 1420 Gray Highway Apt. Office Macon GA 31211 (80)
Indian Lake 102 Indian Lake Drive Morrow GA 30260 (243)
Greenbriar Glen (Colony Woods) 3030 Continental Colony Pkwy. #1105 Atlanta GA 30331 (74)
Marsh Landing 3875 Darien Hwy #1A Brunswick GA 31525 (105)
Link Terrace 110 Link Street #1A Hinesville GA 31313 (54)
Quail Call 2414 North Brierwood Rd #55 Albany GA 31705 (55)
Glen Arm Manor 2609 Gillionville Road Apt. 3-A Albany GA 31707 (70)
Westway 2006 South Commercial Dr. Brunswick GA 31525 (70)
Stewart Way 302 W. General Stewart Way #1A Hinesville GA 31313 (191)
Wilcrest Woods 701 Penn Waller Rd. Apt A-1 Savannah GA 31410 (68)
King's Colony 1425 Kings George Blvd. - Leasing Office Savannah GA 31419 (89)
Applegate 2230 Applegate Dr. Columbus IN 47203 (58)
Meadowood 820 Hospital Rd - Office Franklin IN 46131 (51)
Stonehenge 3735 South A - Leasing Office Richmond IN 47374 (59)
Stonehenge 7980 Dunston Drive Indianapolis IN 46239 (60)
Willowood East 3749 Willowood Drive Indianapolis IN 46235 (120)
Willow Run One Plaza Drive New Albany IN 47150 (64)
Beckford Place 2900 S. Memorial Drive - Office New Castle IN 47362 (41)
Annhurst 4958 Dawn Drive Indianapolis IN 46268 (83)
Olivewood 2069 Olivewood Drive Indianapolis IN 46219 (127)
Spicewood 3714 Bartlett Ave Indianapolis IN 46227 (49)
Rosewood Commons 5549 Rosewood Commons Dr. Indianapolis IN 46254 (172)
Cambridge Commons 4959 Oakhurst Drive Indianapolis IN 46254 (234)
Sherbrook 8026 Mcfarland Court Indianapolis IN 46227 (76)
Cherry Glen 2760 Cherry Glen Way Indianapolis IN 46227 (137)
Slate Run 850 N. Elm Street Hopkinsville KY 42240 (57)
Heathmoore 41299 Heathmoore Court Canton MI 48187 (110)
Roanoke 6 Roanoke Lane Rochester Hills MI 48309 (88)
Wentworth 27010 Wentworth Dr. Roseville MI 48066 (75)
Cedargate 1410 Sheridan Dr. #3A Lancaster OH 43130 (157)
Plumwood 1052 Plumrose Drive Columbus OH 43228 (143)
West Of Eastland 3752 Knightsway Lane Columbus OH 43232 (123)
Parkville 2346 Parkgreen Place Columbus OH 43229 (100)
The Willows 2228 Bruce Rd. #67 Delaware OH 43015 (134)
Millburn Court 8324 Millwheel Drive Centerville OH 45458 (115)
Camellia Court 4542 Kalida Ave. Dayton OH 45424 (110)
Andover Court 1095-A Beech St. Mt. Vernon OH 43050 (51)
Greenglen 2015 N. Mccord Rd. #133 Toledo OH 43615 (58)
Springwood 5470 Yellowbud Drive Columbus OH 43231 (64)
Stillwater Landing 4341 Foxton Court Dayton OH 45414 (79)
Meadowood 798 West Straub Rd #12 Mansfield OH 44904 (49)
Sandalwood 4804 W. Bancroft St. Toledo OH 43615 (50)
Stonehenge 799-A 17th Street N.W. Office Massillon OH 44647 (60)
Cedargate 701 N. Union Blvd. Apt #50 Englewood OH 45315 (130)
Woodlands 833 Frost Road Streetsboro OH 44241 (120)
Meadowood 3202 Prange Drive Cuyahoga Falls OH 44223 (59)
Rosewood 5554 Covert Drive Columbus OH 43231 (89)
Montgomery Court 7884 Rhapsody Drive Dublin OH 43016 (117)
Winthrop Court 2531 Arborview Drive Columbus OH 43229 (100)
Sherbrook 6677 Guinevere Columbus OH 43229 (60)
Ashford Hills 1367 Beeler Drive Reynoldsburg OH 43068 (77)
Amesbury 3155 Harshman Drive Reynoldsburg OH 43068 (149)
Red Deer 2201 Roseanne Court Fairborn OH 45324 (131)
Amberwood 3648-A Wales Ave Nw Massillon OH 44646 (63)
https://www.relianceglobalholdings.com/properties
http://EzraBeyman.org
$EOMN
Quote:
Ezra Beyman, EOMN’s CEO, stated, “We are delighted with EOMN’s continuing to make acquisitions in the insurance agency space, and we also intend to make real estate acquisitions. We have significant experience in both sectors, and, at the appropriate time, we intend to become a SEC-reporting company again.
EOMN also announces that it has changed EOMN’s corporate name in the State of Florida to RELIANCE GLOBAL GROUP, INC., and is now applying to FINRA for a symbol change
TREP - A featured P2DI company
Time and Sales
https://ih.advfn.com/stock-market/USOTC/trucept-inc-pc-TREP/trades
TREP meets this criteria in sticky post
TREP - looks powerful...At a critical point of a dime. A bid close over a dime before the next cycle up would be a awesome sign....Should be a really interesting November - P2DI plays climb in powerful stages...
TREP - Has the right fundamentals and sizzle to be a P2DI. The real easy money has been made from double zeros but it still had a second up cycle and looking for a 3rd next week. If the strength continues and the company PRs performance info...A dollar plus is really possible
$RXMD NEWS GROWTH AGAIN!
Progressive Care Inc. Announces Month-End Sales Figures Showing Increase in Year-Over-Year Prescriptions Filled in June 2018
Press Release 07/17/2018
MIAMI, July 17, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and technology company, today announced further growth year-over-year in both revenue and number of prescriptions filled for June 2018.
Progressive Care’s wholly owned subsidiary PharmCo, LLC has seen an 18.75% increase in prescriptions filled over the same month last year, totaling approximately 22,500 prescriptions.
June brought a total revenue of roughly $1.65 million in net revenues, a slight decrease from last year in the same month.
WHY THE SIGNIFICANT GROWTH WILL CONTINUE!
RXMD Up 30% Today on acquisition completion news.
We are halfway through 2018 and just completed our second location acquisition (TouchPointRX on 7/2/18), and just hired a company 6/27/18 who is feverishly working for the SOLE GOAL of getting us prepared for UPLIST to NASDAQ in first part of 2019. Whatever forces at work will not be able to keep down an over 20 Million NET Revenue producing company from just the 1 location for very long. This will touch .25 again and this will touch .50 prior to NASDAQ uplist.
Today's TouchPointRX acquisition Press Release and 6/27 Benchmark Investment Banking Firm Agreement Press Release is just confirmation of this statement below from CEO Ms. Mars at about the 46 minute mark of 1st quarter call, who is great by the way!
Quarterly Conference Call https://smallcapvoice.com/blog/progressive-care-inc-reports-largest-single-revenue-quarter-in-company-history/
"I want to talk about the future, what our mission is. Why are we growing Pharmco? Why are we growing Progressive Care? Because we are a healthservices company, because we believe we are needed. We are attempting to fill all gaps in a patient's healthcare. That is why we are here, that is why we are growing. TouchPointRX is just the first step in our expansion, we want to go as far as our will will take us. Doing over 20 million in South Florida. We are leading the thought on how healthcare should be. We will grow through acquisitions, and will become a leader in the healthcare space. I understand pessimism, I understand skeptism. But for anybody that doesn't believe you need to get out of our way, because bigger things have tried to take down Progressive Care. Nothing will stop us from becoming what we are destined to be. Nothing will stop us from becoming SEC reporting, nothing will stop us from uplisting to a higher National Exchange. Today is the beginning, and we are on the cusp of more. It doesn't matter what share price is today, the only thing is it won't be there much longer. We will make any investor proud!"
$RXMD - RXMD IS ON A COURSE FOR SUCCESS, ON OTCQB and NASDAQ
RXMD BOARD https://investorshub.advfn.com/Progressive-Care-Inc-RXMD-19843/
OUTLOOK FOR 2018: Completion of TWO REVENUE PRODUCING ACQUISTIONS
OUTLOOK FOR 2019: SEC Reporting Compliance, NASDAQ Uplist, and more ACQUISITIONS per CEO Ms. Shital Mars in last quarterly conference call. https://smallcapvoice.com/blog/progressive-care-inc-reports-largest-single-revenue-quarter-in-company-history/
ALL POINTS TO CONTINUED DEVELOPMENT AND GROWTH THROUGH EXPANSION ****INVEST WISELY****
WITH EXTREMELY LOW SHARE STRUCTURE
500 MILLION AUTHORIZED
426 MILLION OUTSTANDING
HERES SOME JUICY 2018 NUMBERS - W/O NEW LOCATION ACQUIRED 3/30/18, these revenues will start to be recognized June 30, 2018
Scripts: 109,600 a 24% increase compared to May 31, 2017
Net Revenue: $8.53 million, a $280,000+ increase compared to May 31, 2017
340B Sales: $2.35 million, a $1.49 million+ increase compared to May 31, 2017
Annualized, 2018 340B Sales are estimated at $6.2 Million, that's nearly a 125% increase of 2017's $2.75 Million.
PharmCoRX is obviously increasing the number of customers.
KEY PHARMACIST COMPENSATION SAVINGS: $473,000 estimated for 2018
Management restructured Key Pharmacist agreement October 1, 2017 to reduce costs, which resulted in a savings of $173,000 compared to last year as recognized in 1st Quarter Results with this F/S Note: During the three months ended March 31, 2018 and 2017, payments to the pharmacist were approximately $87,000 and $260,000, respectively. $87K x 4 = $348 compared to FY 2017 of $821K. This puts us on pace for savings of over $473,000 for 2018
Let’s Take a Very Close Look with the Eyeball on 1st Quarter Results
So we reported $(642,000) Loss.
What really makes up that Loss and Is True Profitability Reflected.
Let’s start from the Net Loss and then dive into the expenses and see what’s really related to Operations.
This completely agrees with F/S information below, which doesn’t take it as far to perform the addbacks to assess RXMD’s true profitability.
$RXMD OVER 20 MILLION NET REVENUES 2017
Just acquired a new second location not included in figures below until after 6/30/2018 finalization of acquisition.
RXMD BOARD https://investorshub.advfn.com/Progressive-Care-Inc-RXMD-19843/
Quarterly Conference Call https://smallcapvoice.com/blog/progressive-care-inc-reports-largest-single-revenue-quarter-in-company-history/
Quick Summary of how RXMD (PharmcoRX) is achieving significant GROWTH RIGHT NOW. Remember 90% of the companies on the OTC don't even have revenues or profits. LOL
RXMD has both and a ton of revenues. Over $20 million net revenues for FY 2018.
NPHC - HOLDS PATENTED SOLUTION TO THE OPIOID CRISIS
NYLOXIN IS AWAITING DISTRIBUTION ON THE FSS AND GSA ADVANTAGE
The compilation of all these posts will help bring you up to speed To understand the process of getting NYLOXIN distributed to the government. Nyloxin is on the verge of completing the GSA listing process. Here is DD to support this belief
Thanks to BMOC91324 for calling Debra the CEO of EuroAmerican and posting this excellent DD:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=139932525
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=140061138
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=140092902
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=140034640
Nutra Pharma Partners with EuroAmerican IP to Distribute Nyloxin® for Sale to Government Agencies
PRESS RELEASE:
https://globenewswire.com/news-release/2018/01/18/1296478/0/en/Nutra-Pharma-Partners-with-EuroAmerican-IP-to-Distribute-Nyloxin-for-Sale-to-Government-Agencies.html
“We are excited to be working with Nutra Pharma,” commented Debra J Paul, CEO, and Tami Dana, COO, of EuroAmerican. “Nyloxin is an exciting alternative to opiate drugs. We believe that it can be a significant tool for combatting opioids in our veterans and in our military,” they continued. “We have seen that Nyloxin substantially reduces all types of pain without mental confusion, addiction or toxicity. We believe that we can quickly and successfully add the Nyloxin products to our existing product list for distribution through our Federal Supply Schedule #V797D-40251 to be available as a replacement for opioids and other pain management drugs” they concluded.
EuroAmerican IP, LLC has been delivering Federal Supply Schedule Commodities to the BOP, DHS, DOJ, DOD, FBI, USCG, HHS, NIH, SSA, VA and other governmental agencies since 2009. Currently offering over 100 contracted items to VA's and OGA's. EAIP is proud to comment that we have only received excellent feedback and appreciation from loyal customers.
Opioid abuse crisis takes heavy toll on US Veterans...
NPHC has a SOLUTION
November 10, 2017
NEW YORK –Opioid drug abuse has killed more Americans than the Iraq, Afghanistan and Vietnam wars combined, and U.S. veterans and advocates this Veteran's Day are focusing on how to help victims of the crisis.
Veterans are twice as likely as non-veterans to die from accidental overdoses of the highly addictive painkillers, a rate that reflects high levels of chronic pain among vets, particularly those who served in the wars in Iraq and Afghanistan, according to federal data.
U.S. government and healthcare officials have been struggling to stem the epidemic of overdoses, which killed more than 64,000 Americans in the 12 months ending last January alone, a 21 percent increase over the previous year, according to the Centers for Disease Control. About 65,000 Americans died in Vietnam, Iraq and Afghanistan.
President Donald Trump named opioids a NATIONAL PUBLIC HEALTH EMERGENCY and a White House commission last week recommended establishing a nationwide system of drug courts and easier access to alternatives to opioids for people in pain.
"Our veterans deserve better than polished sound bites and empty promises," said former Democratic Congressman Patrick Kennedy, a recovering addict and a member of the president's opioid commission.
http://www.foxnews.com/health/2017/11/10/opioid-abuse-crisis-takes-heavy-toll-on-us-veterans.htm
THE TIME IS NOW...
IT IS A NATIONAL CRISIS...
NPHC HAS A REAL VIABLE SOLUTION!!!
AS WE SPEAK ITS IN THE PROCESS OF BECOMING DISTRIBUTED TO THE US GOVERNMENT!!
Nutra Pharma Partners with NxGen Brands for Nyloxin® Distribution
PRESS RELEASE:
https://www.nutrapharma.com/single-post/2018/04/19/Nutra-Pharma-Partners-with-NxGen-Brands-for-Nyloxin®-Distribution
“We are pleased to be working with NxGen Brands to expand the marketing of Nyloxin,” explained Rik J Deitsch, Chairman and CEO of Nutra Pharma Corporation. “Over the past year, we have brought the Nyloxin product line back under our control and have updated our own websites. These efforts to increase internet awareness will continue as we join other marketing groups to greatly expand our reach to educate consumers about Nyloxin and get the product into the hands of those who need it most,” he continued. “We will also be working with NxGen Brands in our capacity as consultants to aid in expanding their in-house product line, improve their manufacturing and look for other synergies for combined growth,” he concluded.
OPENED UP ANOTHER DISTRIBUTION CHANNEL!
MARKETING NYLOXIN TO THE GENERAL POPULATION!
ANOTHER BUILDING BLOCK TO CREATING AWARENESS AND INCREASING SALES!!
Nutra Pharma Announces Nyloxin® Distribution Agreement for Australia and New Zealand
PRESS RELEASE:
https://globenewswire.com/news-release/2018/02/01/1330073/0/en/Nutra-Pharma-Announces-Nyloxin-Distribution-Agreement-for-Australia-and-New-Zealand.html
“We recently announced our domestic efforts to increase sales and distribution of Nyloxin," stated Rik J Deitsch, Chairman and CEO of Nutra Pharma Corporation. "This included the new website, web promotions and our application to be added to the Federal Supply Schedule for sales to US governmental agencies,” he continued. “I'm excited to announce that we have also been working to promote our products internationally. We have been moving forward with our efforts in Canada and India – and we are now announcing our agreement with Pharmachal to be our exclusive distributor of Nyloxin in Australia and New Zealand. Once they receive regulatory approval through the TGA, they will be able to warehouse, market and distribute Nyloxin throughout their territories. We believe this will allow for broad distribution and marketing in that region by the end of this year,” he concluded.
NYLOXIN TO BE DISTRIBUTED AND MARKETED INTERNATIONALLY.
CANADA AND INDIA ARE NEXT...
FACTS ABOUT NYLOXIN Non addictive pain solutions - OPIOID Alternative (FDA Registered)
* Amazon today
* NPHC Controls all patents
* Seeking Nyloxin distributors: Israel, South Africa, Canada, Central and South America
* Currently in 100 pharmacy's and doctors offices
* Working with Military and VA.
* https://nyloxin.com/
* Supported by Jack Brewer.(On Twitter) Executive Chairman & Portfolio Manager of The Brewer Group.
(Very successful investor/financier and has connections with Bio Tech)
Nyloxin is all-natural, anti-inflammatory, analgesic pain relief that is non-toxic, non-narcotic, non-addictive, non-steroidal and does not contain aspirin or acetaminophen !!!
"Nyloxin product is amazing. It’s non-addictive, no opiate, non-narcotic In the last model, it outperformed morphine. It lasted 4-6 hours longer than morphine without any of the side effects. Additionally, since the dose of Nyloxin is so small compared to the dose of morphine required, the Nyloxin was considered to be approximately 600 times more potent than the morphine on a molecular basis,” explained Rik Deitsch, CEO of Nutra Pharma Corp..
"We have also stated that there are no contraindications in utilizing the Nyloxin with opiate drugs. In fact, since their mechanisms of action are so vastly different, we have seen a synergistic benefit. The recommendation is to continue the use of the opiate while introducing Nyloxin to the patient protocol. After a few weeks, most people can reduce their opiate use and many people have even eliminated their use of opiates over time in favor of the Nyloxin". He continued.
NYLOXIN IS A REVOLUTIONARY OPIOID SOLUTION IN MIDST OF A OPIOD REVOLUTION!
ALL THE DD ABOVE demonstrates how there is more going on today than ever!!
NPHC was at 140 million dollar market cap just 3yrs ago with LESS THAN WE HAVE TODAY!!
Let that sink in......... NPHC is way UNDERVALUED here at 5Million dollar MC!
THE MARKET CAP CORRECTION IS COMING...
Mark. it.
Mav
Followers
|
66
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
385
|
Created
|
02/25/14
|
Type
|
Premium
|
Moderator The_Free_Nebula | |||
Assistants |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |